Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 6
1980 3
1981 3
1982 9
1983 10
1984 7
1985 10
1986 6
1987 2
1988 3
1989 5
1990 8
1991 2
1992 6
1993 8
1994 6
1995 7
1996 12
1997 19
1998 13
1999 17
2000 32
2001 18
2002 62
2003 32
2004 59
2005 63
2006 71
2007 70
2008 71
2009 64
2010 69
2011 63
2012 78
2013 82
2014 73
2015 61
2016 60
2017 64
2018 62
2019 65
2020 71
2021 65
Text availability
Article attribute
Article type
Publication date

Search Results

1,361 results
Results by year
Filters applied: . Clear all
Page 1
Amisulpride.
[No authors listed] [No authors listed] 2021 Apr 19. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Apr 19. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000816 Free Books & Documents. Review.
Excretion of amisulpride into breastmilk is higher than with other pharmacologically similar drugs. Most information on amisulpride is with continuous oral use as a psychotherapeutic agent. ...
Excretion of amisulpride into breastmilk is higher than with other pharmacologically similar drugs. Most information on amisulprid
Amisulpride.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2020 Nov 16;77(23):1917-1918. doi: 10.1093/ajhp/zxaa292. Am J Health Syst Pharm. 2020. PMID: 33196816 No abstract available.
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T. Barnes TR, et al. Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490. Health Technol Assess. 2017. PMID: 28869006 Free PMC article. Clinical Trial.
INTERVENTIONS: Interventions comprised clozapine augmentation over 12 weeks with amisulpride or placebo. Participants received 400 mg of amisulpride or two matching placebo capsules for the first 4 weeks, after which there was a clinical option to titrate the dosage …
INTERVENTIONS: Interventions comprised clozapine augmentation over 12 weeks with amisulpride or placebo. Participants received 400 mg …
A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting.
Fox G, Kranke P. Fox G, et al. Expert Rev Clin Pharmacol. 2020 Apr;13(4):331-340. doi: 10.1080/17512433.2020.1750366. Epub 2020 Apr 15. Expert Rev Clin Pharmacol. 2020. PMID: 32245336 Review.
AREAS COVERED: This review article summarizes the published data on the clinical pharmacology, safety, and efficacy of intravenous amisulpride as an antiemetic, supplemented by published data on oral amisulpride, where relevant to the intravenous form. Literature wa …
AREAS COVERED: This review article summarizes the published data on the clinical pharmacology, safety, and efficacy of intravenous amisul
A systematic review and combined meta-analysis of concentration of oral amisulpride.
Li L, Li L, Shang DW, Wen YG, Ning YP. Li L, et al. Br J Clin Pharmacol. 2020 Apr;86(4):668-678. doi: 10.1111/bcp.14246. Epub 2020 Mar 3. Br J Clin Pharmacol. 2020. PMID: 32090363 Free PMC article. Review.
This study aims to clarify the impact of dose, sex, age and related factors for the interpatient variability in amisulpride plasma/serum concentration. METHODS: Both English and Chinese databases were searched from their inception to May 16, 2019, using the terms: amisu
This study aims to clarify the impact of dose, sex, age and related factors for the interpatient variability in amisulpride plasma/se …
Amisulpride as an Augmentation Agent in Treatment Resistant Depression: A Case Series and Review of the Literature.
Rittmannsberger H. Rittmannsberger H. Psychiatr Danub. 2019 Jun;31(2):148-156. doi: 10.24869/psyd.2019.148. Psychiatr Danub. 2019. PMID: 31291218 Free article. Review.
Amisulpride (AMS) in low dosage has been used effectively for treatment of dysthymia. ...We deal with this issue presenting case reports and a review of the literature. The addition of 50 mg amisulpride (AMS) to antidepressant therapy in seven patients with depressi
Amisulpride (AMS) in low dosage has been used effectively for treatment of dysthymia. ...We deal with this issue presenting case repo
Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.
Men P, Yi Z, Li C, Qu S, Xiong T, Yu X, Zhai S. Men P, et al. BMC Psychiatry. 2018 Sep 5;18(1):286. doi: 10.1186/s12888-018-1867-8. BMC Psychiatry. 2018. PMID: 30185173 Free PMC article.
Since more Chinese patients are gaining access to amisulpride, the study aims to compare the efficacy, safety, and costs between amisulpride and olanzapine for schizophrenia treatment in China. ...CONCLUSION: As the first meta-analysis and cost-minimization analysis …
Since more Chinese patients are gaining access to amisulpride, the study aims to compare the efficacy, safety, and costs between a
Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis.
Candiotti KA, Kranke P, Bergese SD, Melson TI, Motsch J, Siddiqui N, Chung F, Rodriguez Y, Minkowitz HS, Ayad SS, Diemunsch P, Fox G. Candiotti KA, et al. Anesth Analg. 2019 Jun;128(6):1098-1105. doi: 10.1213/ANE.0000000000003733. Anesth Analg. 2019. PMID: 31094774 Clinical Trial.
This study was designed to determine if amisulpride could be used to treat established PONV in patients at low-to-moderate risk of PONV who had not received any prior prophylaxis. ...Complete response occurred in 39 of 181 patients (21.5%) in the placebo group compared to …
This study was designed to determine if amisulpride could be used to treat established PONV in patients at low-to-moderate risk of PO …
Amisulpride for schizophrenia.
Mota NE, Lima MS, Soares BG. Mota NE, et al. Cochrane Database Syst Rev. 2002;2002(2):CD001357. doi: 10.1002/14651858.CD001357. Cochrane Database Syst Rev. 2002. PMID: 12076408 Free PMC article. Review.
They also contacted authors of trials and the manufacturer of amisulpride. SELECTION CRITERIA: All randomised controlled trials comparing amisulpride to placebo, typical or atypical antipsychotic drugs for schizophrenia or other non-affective serious mental illnesse …
They also contacted authors of trials and the manufacturer of amisulpride. SELECTION CRITERIA: All randomised controlled trials compa …
An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting.
Smyla N, Koch T, Eberhart LH, Gehling M. Smyla N, et al. Expert Opin Pharmacother. 2020 Apr;21(5):517-522. doi: 10.1080/14656566.2020.1714029. Epub 2020 Jan 23. Expert Opin Pharmacother. 2020. PMID: 31971450 Review.
Droperidol's use has significantly declined after the FDA's black-box warning in 2001 due to its QT-prolonging properties. Amisulpride is a promising antiemetic agent which could fill this gap.Areas covered: In this review, the authors discuss the pharmacological profile a …
Droperidol's use has significantly declined after the FDA's black-box warning in 2001 due to its QT-prolonging properties. Amisulpride
1,361 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page